DELTA, BC — Phyton Biotech LLC. proudly announces a significant milestone in its journey toward advancing pharmaceutical research and development. The Company is pleased to announce the receipt of its Controlled… Read More
INM-089 improves retinal function in in vivo preclinical AMD disease model Establishes cannabinol (CBN) analog candidate in a new disease target VANCOUVER, BC — InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the… Read More
VANCOUVER, BC — Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the clinical-stage pharmaceutical company developing psilocybin therapy for alcohol use disorder (AUD), announced that it has randomized more than 50 per cent of… Read More
KIMBERLY, BC — LifeLabs, Canada’s leading provider of medical diagnostic services and recognized as the most trusted brand in health diagnostic services by Canadians, is thrilled to announce the relocation and… Read More
VANCOUVER, BC, TORONTO, ON, and MONTREAL, QC — adMare BioInnovations (adMare) is pleased to welcome 22 life sciences leaders to Cohort VI of the adMare Academy’s Executive Institute. The adMare… Read More
